The stock of Craneware plc (LON:CRW) gapped down by GBX 5 today and has GBX 874.00 target or 8.00% below today’s GBX 950.00 share price. The 6 months technical chart setup indicates high risk for the GBX 257.61 million company. The gap down was reported on Nov, 24 by Barchart.com. If the GBX 874.00 price target is reached, the company will be worth GBX 20.61 million less.
Gaps down are helpful for identifying a resistance level and to could also be used as a tradeable event. If traders are short the stock and it experiece gap down, then its usually advisable to hold the short for a bigger down move. Back-tests of such patterns show that two-thirds of the these patterns the stock performance worsens after the gap. The area gaps close 91% of the time, the breakaway gaps 1%, the continuation gaps 9% and the exhaustion gaps 64%. The stock decreased 5.71% or GBX 57.5 on November 24, hitting GBX 950. About 22,614 shares traded hands or 2.78% up from the average. Craneware plc (LON:CRW) has risen 21.38% since April 28, 2016 and is uptrending. It has outperformed by 15.97% the S&P500.
Craneware plc (LON:CRW) Ratings Coverage
Out of 3 analysts covering Craneware (LON:CRW), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Craneware has been the topic of 18 analyst reports since July 16, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Tuesday, March 8 by Peel Hunt. Peel Hunt maintained the shares of CRW in a report on Monday, January 11 with “Buy” rating. Peel Hunt maintained the shares of CRW in a report on Monday, March 14 with “Buy” rating. The firm earned “Buy” rating on Friday, January 22 by Investec. The stock of Craneware plc (LON:CRW) has “Buy” rating given on Thursday, September 15 by Peel Hunt. Peel Hunt maintained the stock with “Buy” rating in Wednesday, July 6 report. The company was maintained on Wednesday, July 13 by Peel Hunt. The rating was maintained by Peel Hunt on Thursday, November 10 with “Buy”. Peel Hunt maintained the shares of CRW in a report on Tuesday, September 6 with “Buy” rating. The firm earned “Buy” rating on Tuesday, November 15 by Peel Hunt.
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The company has a market cap of 257.61 million GBP. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention. It has a 30.34 P/E ratio. The Company’s Patient Engagement solutions include InSight Medical Necessity, Trisus Patient Payment and Patient Charge Estimator.